Utility of 68Ga-PSMA PET / CT in occult biochemical recurrence of prostate carcinoma with negative 18F-Choline PET / TC. Our experience

被引：0
|
作者：
Plaza Lopez, P. [1 ]
Puertas, E. [1 ]
Aguilo, J. [1 ]
Domenech, B. [1 ]
Sanjose, S. [1 ]
Suarez-Pinera, M. [2 ]
Rivera, E. [3 ]
Casals, J. [1 ]
Chicharo, J. [4 ]
机构：
[1] Hosp Quironsalud Barcelona, Barcelona, Spain
[2] Hosp del Mar Barcelona, Barcelona, Spain
[3] Hosp Dexeus Barcelona, Barcelona, Spain
[4] Univ Malaga, Fdn Gen, Cimes, Malaga, Spain
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-172
引用
收藏
页码：S592 / S593
页数：2
相关论文
共 50 条
  • [21] 68Ga-PSMA PET/CT in prostate cancer
    Garcia Garzon, J. R.
    de Arcocha Torres, M.
    Delgado-Bolton, R.
    Ceci, F.
    Alvarez Ruiz, S.
    Orcajo Rincon, J.
    Caresia Aroztegui, A. P.
    Garcia Velloso, M. J.
    Garcia Vicente, A. M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2018, 37 (02): : 130 - 138
  • [22] Therapy impact of 18F-PSMA PET/CT in biochemical recurrence of prostate cancer patients with PSA< 1 ng/ml postprostatectomy and 18F-Choline PET/CT negative
    Cozar Santiago, M.
    Garcia Garzon, J.
    Pastor Peiro, J.
    Bassa Massanas, P.
    Canoves Llombart, A.
    Aguilar Barrios, J.
    Sanz Llorens, R.
    Faus Rodrigo, V.
    Soler Lopez, M.
    Ferrer Rebolleda, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S266 - S266
  • [23] 68Ga-PSMA PET/CT Versus 18F-FDG PET/CT for Imaging of Hepatocellular Carcinoma
    Gundogan, Cihan
    Ergul, Nurhan
    Cakir, Mehmet Semih
    Kilickesmez, Ozgur
    Gursu, Riza Umar
    Aksoy, Tamer
    Cermik, Tevfik Fikret
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2021, 30 (02) : 79 - 85
  • [24] Rectal Carcinoma on 68Ga-PSMA PET/CT
    Huang, Yi-Tung Tom
    Fong, William
    Thomas, Paul
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (03) : E167 - E168
  • [25] Impact of 68Ga-PSMA PET/CT in prostate cancer patients with biochemical recurrence after surgery
    Bartoncini, S.
    Nicolotti, D.
    Deandreis, D.
    Guarneri, A.
    Zitella, A.
    Passera, R.
    Parise, R.
    Bello, M.
    Lillaz, B.
    Bisi, G.
    Gontero, P.
    Ricardi, U.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S856 - S857
  • [26] Evaluation of Predictors of Biochemical Recurrence in Prostate Cancer Patients, as Detected by 68Ga-PSMA PET/CT
    Christensen, Mads T.
    Jochumsen, Mads R.
    Klingenberg, Soren
    Sorensen, Karina D.
    Borre, Michael
    Bouchelouche, Kirsten
    DIAGNOSTICS, 2022, 12 (01)
  • [27] Role of 68Ga-PSMA PET/CT in men with biochemical recurrence after definitive treatmentofadenocarcinoma prostate
    Kumar, R.
    Sharma, A.
    Kumar, S.
    Das, C.
    Seth, A.
    Pandey, A.
    Patel, C.
    Estrada-Lobato, E.
    Cerci, J.
    Fanti, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S590 - S590
  • [28] 18F-choline PET/MRI in suspected recurrence of prostate carcinoma
    Riola-Parada, C.
    Carreras-Delgado, J. L.
    Perez-Duenas, V
    Garcerant-Tafur, M.
    Garcia-Canamaque, L.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2018, 37 (05): : 296 - 301
  • [29] 68Ga-PSMA PET/CT in Postoperative PCa Recurrence
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (07) : 17N - 17N
  • [30] Value of 18F-Choline PET/CT in restaging of prostate cancer patients with biochemical recurrence
    Beheshti, M.
    Wolf, I.
    Steinmayer, M.
    Broinger, G.
    Kirchweger, B.
    Nader, M.
    Loidl, W.
    Hammer, J.
    Langsteger, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S270 - S270
12345